Insider Transactions in Q1 2024 at Leap Therapeutics, Inc. (LPTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 26
2024
|
John Mark O'Mahony Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Jan 26
2024
|
Christopher Mirabelli Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+49.57%
|
-
|
|
Jan 26
2024
|
Douglas E Onsi CEO,CFO,Pres.,GC,Treas.&Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.24%
|
-
|
|
Jan 26
2024
|
Augustine Lawlor Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+49.57%
|
-
|
|
Jan 26
2024
|
Cynthia Sirard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|